1. Chang, Qing-Hua, Mao, Ting, Tao, Yan, Ge, Guo-Hong, Xu, Zi-Jun. 2021. Pan-cancer analysis identifies ITIH1 as a novel prognostic indicator for hepatocellular carcinoma. In Aging, 13, 11096-11119. doi:10.18632/aging.202765. https://pubmed.ncbi.nlm.nih.gov/33744857/
2. Qian, Xu, Bao, Zhong-Ming, Yao, Dan, Shi, Yang. 2022. Lysine demethylase 5C epigenetically reduces transcription of ITIH1 that results in augmented progression of liver hepatocellular carcinoma. In The Kaohsiung journal of medical sciences, 38, 437-446. doi:10.1002/kjm2.12501. https://pubmed.ncbi.nlm.nih.gov/35080113/
3. Gao, Jing, Yu, Gang, Yan, Yan, Wei, Jing, Yang, Shiquan. 2024. ITIH1 suppresses carcinogenesis in renal cell carcinoma through regulation of the NF‑κB signaling pathway. In Experimental and therapeutic medicine, 28, 368. doi:10.3892/etm.2024.12657. https://pubmed.ncbi.nlm.nih.gov/39091412/
4. Léveillard, T, Salier, J P, Sesboüé, R, Diarra-Mehrpour, M, Martin, J P. . Dra I polymorphism in the human inter-alpha-trypsin inhibitor heavy chain gene ITIH1. In Nucleic acids research, 17, 5419. doi:. https://pubmed.ncbi.nlm.nih.gov/2474799/
5. Kim, Tae Hyun, Koo, Ja Hyun, Heo, Mi Jeong, Cho, Je-Yoel, Kim, Sang Geon. . Overproduction of inter-α-trypsin inhibitor heavy chain 1 after loss of Gα13 in liver exacerbates systemic insulin resistance in mice. In Science translational medicine, 11, . doi:10.1126/scitranslmed.aan4735. https://pubmed.ncbi.nlm.nih.gov/31597753/
智鼠故事 
